Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IBB NYSEARCA:IXJ NYSEARCA:XBI NYSEARCA:XLV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$171.44-0.4%$170.38$123.61▼$179.64$8.09B0.721.39 million shs1.03 million shsIXJiShares Global Healthcare ETF$94.67-0.2%$93.83$82.16▼$101.78$3.68B0.58275,555 shs885,011 shsXBISPDR S&P Biotech ETF$135.34-0.8%$132.91$80.90▼$139.19$8.63B0.859.16 million shs6.91 million shsXLVHealth Care Select Sector SPDR Fund$152.94+0.0%$147.96$127.96▼$160.59$40.09B0.5812.53 million shs8.61 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF-0.42%+1.23%+2.76%+4.68%+34.09%IXJiShares Global Healthcare ETF-0.17%-1.61%+2.94%+1.91%+9.41%XBISPDR S&P Biotech ETF-0.78%+3.01%+3.56%+11.75%+62.34%XLVHealth Care Select Sector SPDR Fund+0.03%-1.05%+5.40%+3.94%+12.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIBBiShares Biotechnology ETF$171.44-0.4%$170.38$123.61▼$179.64$8.09B0.721.39 million shs1.03 million shsIXJiShares Global Healthcare ETF$94.67-0.2%$93.83$82.16▼$101.78$3.68B0.58275,555 shs885,011 shsXBISPDR S&P Biotech ETF$135.34-0.8%$132.91$80.90▼$139.19$8.63B0.859.16 million shs6.91 million shsXLVHealth Care Select Sector SPDR Fund$152.94+0.0%$147.96$127.96▼$160.59$40.09B0.5812.53 million shs8.61 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIBBiShares Biotechnology ETF-0.42%+1.23%+2.76%+4.68%+34.09%IXJiShares Global Healthcare ETF-0.17%-1.61%+2.94%+1.91%+9.41%XBISPDR S&P Biotech ETF-0.78%+3.01%+3.56%+11.75%+62.34%XLVHealth Care Select Sector SPDR Fund+0.03%-1.05%+5.40%+3.94%+12.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIBBiShares Biotechnology ETF 2.72Moderate Buy$171.44N/AIXJiShares Global Healthcare ETF 2.76Moderate Buy$94.67N/AXBISPDR S&P Biotech ETF 2.75Moderate Buy$135.34N/AXLVHealth Care Select Sector SPDR Fund 2.76Moderate Buy$152.94N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AIXJiShares Global Healthcare ETFN/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIBBiShares Biotechnology ETFN/AN/AN/AN/AN/AN/AN/AN/AN/AIXJiShares Global Healthcare ETFN/AN/A21.58N/AN/AN/AN/AN/AN/AXBISPDR S&P Biotech ETFN/AN/A11.47N/AN/AN/AN/AN/AN/AXLVHealth Care Select Sector SPDR FundN/AN/A21.15N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthIBBiShares Biotechnology ETF$0.410.24%N/AN/AN/AIXJiShares Global Healthcare ETF$2.202.32%N/AN/AN/AXBISPDR S&P Biotech ETF$0.440.33%N/AN/AN/AXLVHealth Care Select Sector SPDR Fund$2.501.63%N/AN/AN/ALatest XLV, XBI, IBB, and IXJ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/12/2026IBBiShares Biotechnology ETFQuarterly$0.02380.06%6/15/20266/15/20266/18/2026(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIBBiShares Biotechnology ETF62.45%IXJiShares Global Healthcare ETFN/AXBISPDR S&P Biotech ETFN/AXLVHealth Care Select Sector SPDR FundN/AInsider OwnershipCompanyInsider OwnershipIBBiShares Biotechnology ETFN/AIXJiShares Global Healthcare ETFN/AXBISPDR S&P Biotech ETFN/AXLVHealth Care Select Sector SPDR FundN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIBBiShares Biotechnology ETFN/A47.00 millionN/AOptionableIXJiShares Global Healthcare ETFN/A38.90 millionN/ANot OptionableXBISPDR S&P Biotech ETFN/A63.80 millionN/ANot OptionableXLVHealth Care Select Sector SPDR FundN/A262.11 millionN/ANot OptionableXLV, XBI, IBB, and IXJ HeadlinesRecent News About These Companies3 Ridiculously Cheap Healthcare Stocks to Buy in JuneJune 13, 2026 | 247wallst.comHealth care breadth thrust points to sector rotationJune 11, 2026 | seekingalpha.comHealthcare ETFs: From Broad Exposure to Big BreakthroughsJune 11, 2026 | etftrends.comEETFs That May Provide Investors Protection From Market RisksJune 10, 2026 | zacks.comLikely Sector ETF & Stock Winners From May Jobs ReportJune 10, 2026 | zacks.comMiddle East Erupts Again: Buy these Healthcare ETFs Before the Next StrikeJune 9, 2026 | zacks.comNo tech, no problem. Dow makes record and traders think these stocks can lead nowJune 5, 2026 | cnbc.comUnitedHealth, Eli Lilly lead healthcare rankings as sector gains momentumJune 5, 2026 | seekingalpha.comToo Much Tech in Your Portfolio? ETFs to Help You DiversifyJune 5, 2026 | zacks.comHealthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors.June 5, 2026 | fool.comHumana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost TrendsJune 4, 2026 | 247wallst.comSPDR Sector ETFs: Tech Leads May RallyJune 4, 2026 | etftrends.comEMost and least shorted mid- to mega-cap healthcare stocks at the end of MayJune 3, 2026 | msn.comState Street Health Care Select Sector SPDR ETFJune 2, 2026 | barrons.comSickly healthcare stocks are perking up. For contrarian investors, buying now could be just the remedy to protect your portfolioMay 25, 2026 | msn.comState Street Health Care Select Sector SPDR ETF (XLV)May 20, 2026 | finance.yahoo.comWhen 2022 Tore Through the S&P 500, This Healthcare ETF Barely Flinched. Why Isn’t It in More Retirement Accounts?May 20, 2026 | finance.yahoo.comWhen 2022 Tore Through the S&P 500, This Healthcare ETF Barely Flinched. Why Isn't It in More Retirement Accounts?May 20, 2026 | 247wallst.comDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?May 19, 2026 | 247wallst.comThese Stocks Could Be the Biggest Winners of the 2026 Midterms (XLV)...May 18, 2026 | marketbeat.comWhy the Healthcare Sector Warrants Concentrated ExposureMay 13, 2026 | etftrends.comENew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Iran Ceasefire or Not, These 3 Companies Could WinBy Nathan Reiff | June 15, 20263 Longevity ETFs to Buy and Hold (and Hold)By Nathan Reiff | June 8, 2026XLV, XBI, IBB, and IXJ Company DescriptionsiShares Biotechnology ETF NASDAQ:IBB$171.44 -0.73 (-0.42%) As of 06/16/2026 04:00 PM EasterniShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.iShares Global Healthcare ETF NYSEARCA:IXJ$94.67 -0.16 (-0.17%) As of 06/16/2026 04:10 PM EasterniShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor's Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals. The Underlying Index consists of stocks of companies in countries, including Australia, Belgium, Canada, Denmark, France, Germany, Ireland, Japan, the Netherlands, Switzerland, the United Kingdom and the United States. The Fund's investment advisor is BlackRock Fund Advisors (BFA).SPDR S&P Biotech ETF NYSEARCA:XBI$135.34 -1.06 (-0.78%) As of 06/16/2026 04:10 PM EasternSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.Health Care Select Sector SPDR Fund NYSEARCA:XLV$152.94 +0.05 (+0.03%) Closing price 06/16/2026 04:10 PM EasternExtended Trading$152.80 -0.14 (-0.09%) As of 09:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Health Care Select Sector SPDR Fund (the Fund) seeks to closely match the returns and characteristics of the S&P Health Care Select Sector Index (the Index). The companies included in the Index are selected on the basis of general industry classification from a universe of companies defined by the Standard & Poor's 500 Composite Stock Index (S&P 500). The Health Care Select Sector Index includes companies from the industries, such as pharmaceuticals, healthcare providers and services, healthcare equipment and supplies, biotechnology, life sciences tools and services, and healthcare technology. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index. State Street Global Advisors acts as the Fund's investment manager. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Gravity Check: Houston, SpaceX Has a Valuation Problem Okta’s AI Moment May Be Bigger Than Investors Realize Could a Tesla-SpaceX Merger Be Closer Than Investors Think? Strategy’s Bitcoin Rally Has a Hidden Engine Is Lennar Finally Turning the Corner After Its Housing Slump? Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird Satellites Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
